Effect of Adjunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type 1 Diabetes
- 1 February 2007
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (2) , 210-216
Abstract
OBJECTIVE—To assess the effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes treated with intensive insulin regimens.Keywords
This publication has 25 references indexed in Scilit:
- A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 DiabetesDiabetes Care, 2006
- Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) StudyDiabetic Medicine, 2005
- Standards of Medical Care in DiabetesDiabetes Care, 2005
- Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose‐timing studyDiabetes/Metabolism Research and Reviews, 2004
- Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trialBMJ, 2002
- Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive TherapyNew England Journal of Medicine, 2000
- Amylinʼs physiology and its role in diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 1997
- Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDMDiabetes, 1994
- Amylin concentrations and glucose controlThe Lancet, 1992
- Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications TrialDiabetes Care, 1988